FindTrial
Sign In

Clinical effects of oxytocin prostaglandin anologues versus prostaglandin alone in obstetric patients

Use of combination of oxytocin and prostaglandin analogues versus prostaglandins alone for obstetric indication- An observational comparative study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058815
Enrollment
140
Registered
2023-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery Health Condition 2: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

B J Government Medical College Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both primigravida & multigravida 2. Singleton gestation 3. With Cephalic presentation 4. Having indication of vaginal delivery will be included in the study

Exclusion criteria

Exclusion criteria: 1. Cephalopelvic disproportion 2. Multiple pregnancies 3. Placenta previa 4 Previous uterine surgeries

Design outcomes

Primary

MeasureTime frame
1.Comparison of inducing agent or augmenting agent according to age, parity, stage of labour, effacement of cervix 2. Comparison of Progression of delivery 3. No. of patients required caesarean section 4.Comparison of Foetal APGARTimepoint: baseline, 3 hour, 6 hour,9 hour—

Secondary

MeasureTime frame
1. Labour pain 2. Drug administration & onset of labour time 3. Dilatation, effacement of cervixTimepoint: baseline 3 hour 6 hour 9 hour—

Countries

India

Contacts

Public Contactdr shubhangi parasram ganvir

B J Govt. Medical College Pune Maharashtra

mominmujeeb23@gmail.com9423091265

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026